EndoTool Monarch Medical Technologies
Image
Image

Personalized and Predictive Insulin Dosing Across the Healthcare Enterprise

Monarch Medical Technologies, the maker of the EndoTool Glucose Management System, is the leading provider of precision insulin dosing technology for improved patient outcomes.

Interested in EndoTool?
Complete the form and a member of our team will be in contact to learn more about your glycemic management needs.

"*" indicates required fields

Name*
This field is for validation purposes and should be left unchanged.

Personalized and Predictive Insulin Dosing for the Healthcare Enterprise

Monarch Medical Technologies, the maker of the EndoTool® Glucose Management System, is the leading provider of precision insulin dosing technology for improved patient outcomes.

Personalized and Predictive Insulin Dosing for the Healthcare Enterprise

Monarch Medical Technologies, the maker of the EndoTool® Glucose Management System, is the leading provider of precision insulin dosing technology for improved patient outcomes.
Image
"One of the things we really like about the software is that we’re able to achieve blood glucose control in a much improved time frame for very medically complex patients. This includes patients with significant renal impairment, patients who have been exposed to high doses of steroids, and multiple other conditions. The software is able to take into account a patient’s rapidly changing metabolic condition and accurately dose insulin in a safe way."
Gregory Deines, DO
Division Chief of Diabetes and Endocrinology, Spectrum Health
hexagon icon
  • Home
"EndoTool has not only reduced the risk of hypoglycemia, but also improved our compliance with managing hyperglycemia. Our hospital uses more insulin infusions than ever before because we feel confident in the dosing recommendations EndoTool provides. A key component of success is Monarch’s clinical support team who does an outstanding job training and supporting our facility continually throughout our many years with the software."
Maresa Glass, PharmD, BCCCP, FCCM
Assistant Director Clinical Services, Tampa General Hospital
  • Home
"We currently treat all of our critical care patients on IV insulin with EndoTool and have seen great results with managing the glucose levels of our DKA patients. Our main concern for DKA patients on an insulin drip is to make sure that blood sugar levels do not decreased too quickly. However, after reviewing the DKA patient data where EndoTool was used, we have been very pleased with the outcomes."
Ron Fila, RPh
Clinical Pharmacist, McLaren Northern Michigan
  • Home
Image

Precision Medicine for Inpatient Glycemic Management

Proven, patented algorithms that model, predict and adapt dosing recommendations to each patient and their individual response to insulin, for more precise, safer therapy.

EndoTool SubQ
Image

Intravenous insulin dosing software to manage hyperglycemia while avoiding hypoglycemia

EndoTool SubQ

Basal-bolus subcutaneous insulin dosing software supporting industry guidelines and standards

Hospitals using EndoTool IV have demonstrated better patient outcomes, including:

.009%

hypoglycemia <40 mg/dL1

2-day

ICU LOS reduction2

56%

hyperglycemia reduction3

96%

hypoglycemia reduction4

4.8 hrs

time to control1

75%

higher nursing satisfaction5

100%

adherence to protocol6

34%

time to target reduction3

79%

fewer BG checks3

78%

HAI reduction7

Case Study

Assessing the Impact of EndoTool IV at UPMC Central Pennsylvania

Discover UPMC's approach to a 92% reduction in hypoglycemia, leveraging workflow enhancements and enhanced clinical results with EndoTool IV.
Explore Now
ImageImage

See Why Customers Love EndoTool

Image

Sandy Fogel, MD, FACS

Medical Director of OR Services, Carilion Clinic
Associate Professor of Surgery, Virginia Tech Carilion School of Medicine
Image
"One of the things we really like about the software is that we’re able to achieve blood glucose control in a much improved time frame for very medically complex patients. This includes patients with significant renal impairment, patients who have been exposed to high doses of steroids, and multiple other conditions. The software is able to take into account a patient’s rapidly changing metabolic condition and accurately dose insulin in a safe way."

Gregory Deines, DO

Division Chief of Diabetes and Endocrinology, Spectrum Health
Image
"EndoTool has not only reduced the risk of hypoglycemia, but also improved our compliance with managing hyperglycemia. Our hospital uses more insulin infusions than ever before because we feel confident in the dosing recommendations EndoTool provides. A key component of success is Monarch’s clinical support team who does an outstanding job training and supporting our facility continually throughout our many years with the software."

Maresa Glass, PharmD, BCCCP, FCCM

Assistant Director Clinical Services, Tampa General Hospital
Image
"We currently treat all of our critical care patients on IV insulin with EndoTool and have seen great results with managing the glucose levels of our DKA patients. Our main concern for DKA patients on an insulin drip is to make sure that blood sugar levels do not decreased too quickly. However, after reviewing the DKA patient data where EndoTool was used, we have been very pleased with the outcomes."

Ron Fila, RPh

Clinical Pharmacist, McLaren Northern Michigan
Image
WHY GLYCEMIC MANAGEMENT MATTERS

Learn why adopting best practices in glycemic management is vital to high-quality patient care.

Learn More
ENDOTOOL EVIDENCE LIBRARY

Explore clinical research studies demonstrating the safety and efficacy of EndoTool.

Learn More

Nihil hic munitissimus habendi

Nihil hic munitissimus habendi senatus locus, nihil horum? At nos hinc posthac, sitientis piros Afros. Tityre, tu patulae recubans sub tegmine fagi dolor. Quisque placerat facilisis egestas cillum dolore.

"*" indicates required fields

Name*
This field is for validation purposes and should be left unchanged.